Technical Analysis for TCBP - TC BioPharm (Holdings) plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Up 4 Days in a Row | Strength | 0.00% | |
Up 5 Days in a Row | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
50 DMA Support | Bullish | 6.83% | |
Stochastic Buy Signal | Bullish | 6.83% | |
Narrow Range Bar | Range Contraction | 6.83% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 18 hours ago |
10 DMA Resistance | about 18 hours ago |
60 Minute Opening Range Breakout | about 18 hours ago |
Rose Above 10 DMA | about 18 hours ago |
Up 5% | about 18 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Solid Tumors Immune System Immunotherapy Cancer Treatment Cancer Immunotherapy Cell Therapy Acute Myeloid Leukemia Cell Biology Treatment Of Acute Myeloid Leukemia T Cells Immunotherapy Products
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Solid Tumors Immune System Immunotherapy Cancer Treatment Cancer Immunotherapy Cell Therapy Acute Myeloid Leukemia Cell Biology Treatment Of Acute Myeloid Leukemia T Cells Immunotherapy Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 31.6 |
52 Week Low | 0.8501 |
Average Volume | 5,606,082 |
200-Day Moving Average | 5.92 |
50-Day Moving Average | 1.41 |
20-Day Moving Average | 1.52 |
10-Day Moving Average | 1.54 |
Average True Range | 0.25 |
RSI (14) | 52.38 |
ADX | 34.95 |
+DI | 41.12 |
-DI | 18.26 |
Chandelier Exit (Long, 3 ATRs) | 2.51 |
Chandelier Exit (Short, 3 ATRs) | 1.94 |
Upper Bollinger Bands | 1.96 |
Lower Bollinger Band | 1.08 |
Percent B (%b) | 0.57 |
BandWidth | 57.69 |
MACD Line | 0.00 |
MACD Signal Line | 0.01 |
MACD Histogram | -0.0167 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.74 | ||||
Resistance 3 (R3) | 1.73 | 1.67 | 1.72 | ||
Resistance 2 (R2) | 1.67 | 1.62 | 1.67 | 1.71 | |
Resistance 1 (R1) | 1.62 | 1.60 | 1.64 | 1.63 | 1.70 |
Pivot Point | 1.56 | 1.56 | 1.57 | 1.56 | 1.56 |
Support 1 (S1) | 1.51 | 1.51 | 1.54 | 1.53 | 1.46 |
Support 2 (S2) | 1.45 | 1.49 | 1.45 | 1.45 | |
Support 3 (S3) | 1.40 | 1.45 | 1.44 | ||
Support 4 (S4) | 1.42 |